Sun, May 05, 2024
The recalled drug is used to help control the symptoms of lung diseases, including asthma, chronic bronchitis and emphysema.
More >
Wed, Apr 17, 2024
According to ICICI Securities, these stocks can help investors get a return of up to 28 per cent in the next one year.
Tue, Apr 16, 2024
The acquisition will include Ivia Beaute's brands namely Astaberry, Ikin and Bhimsaini on a worldwide basis, the company said.
Thu, Mar 02, 2023
Stocks to buy: Brokerage firms have recommended five stocks having the potential to yield up to 38 per cent. One may consider the brokerage recommendations for positive yield.
Tue, Feb 28, 2023
Nifty Pharma and BSE Healthcare indices were trading below the flat line as most drug makers like Cipla, Biocon, Dr Reddy’s, and Alkem among others were a mixed bag
Top Gainers & Losers: The Indian markets are not seeing respite despite the oversold positions however the pace of decline has subsided in recent sessions, according to the analyst. Asian Paints, Mahindra & Mahindra were among the top gainers on the Sensex, while Cipla tumbled most by nearly 5 per cent on the NSE today.
The National Pharmaceutical Pricing Authority (NPPA) on Monday fixed the prices under the Drugs (Price Control) Order 2013 based on the decision of the 109th authority meeting held on February 21 this year, according to a PTI report.
Tue, Feb 21, 2023
Brokerages are bullish on Nifty50 companies Bharti Airtel, Hero MotoCorp, ITC, Cipla and PowerGrid. Here's what they recommend on these and other stocks in focus on Dalal Street on Tuesday.
Mon, Feb 20, 2023
Cipla shares suffered steep losses on Feb 20 after the drug maker said US health regulator had issued eight observations on its manufacturing facility in Pitampur, Madhya Pradesh.
In the Nifty50 universe, Divi’s Labs, UltraTech Cement and Tech Mahindra emerged the top gainers whereas Adani Enterprises, Cipla and Britannia were the top laggards.
What are the objections of US FDA on Cipla's plant? How much shares fell due to US FDA objections? Know full details from Nupur.
Cipla share price today BSE, NSE: Cipla shares suffered steep losses on Monday after the drug maker said US health regulator had issued eight observations on its manufacturing facility in Pitampur, Madhya Pradesh. The Cipla stock fell by as much as Rs 69.6 or 6.8 per cent to Rs 956.2 apiece on BSE.
Brokerages are bullish on celebrity investor Rekha Jhunjhunwala-owned Fortis Healthcare citing the company's good growth outlook. They are divided on telecom stocks such as Bharti Airtel and Indus Towers, and skeptical on energy company stocks such as BPCL and ONGC.
Which 20 stocks are included in the list today including Berger Paints, Cipla, JSPL and Eicher Motors? Know list of 20 stocks for profitable trade from Varun Dubey and Kushal Gupta on Traders Diary.
Stock Market HIGHLIGHTS: Indian equity benchmarks Sensex and Nifty50 finished a volatile session in the red on Monday, extending losses to a second back-to-back trading day, amid losses in financial, oil & gas and FMCG shares though gains in IT stocks lent some support. Global markets saw mixed moves ahead of the release of minutes of the Fed's last meeting that could offer more clarity on the trajectory of hikes in benchmark interest rates.
Fri, Feb 10, 2023
Gainers and Losers: Snapping its two-day gaining streak, the 30-share BSE Sensex ended 123.52 points or 0.20 per cent lower at 60,682.70.
Wed, Jan 25, 2023
Cipla Ltd on Wednesday reported 9.93 per cent rise in consolidated net profit to ₹800.96 crore for the quarter ended December 2022. Cipla had earned a net profit of Rs 757 crore in the October-December quarter of the last financial year 2021-22. Watch full news in this video.
Cipla Q3 Results: The drug maker reported a 9.9 per cent year-on-year increase in net profit to Rs 801 crore for the October-December period and revenue growth of six per cent to Rs 5,810.1 crore — both missing analysts' estimates. Cipla shares extended their intraday losses after the earnings announcement.
Shares of Tata Motors and Bajaj Auto were trading flat with a positive bias at Rs 422.40 and Rs 3,693 per share on the NSE in the early morning session on Wednesday.
Mon, Dec 26, 2022
SBI, IndusInd Bank, Cipla may give returns up to 25 per cent on long-term months, say ICICI Securities and Motilal Oswal analysts as Indian shares bounced sharply after last week's bloodbath.
Wed, Dec 21, 2022
To review the Covid preparedness, Union Health Minister Mansukh Mandaviya chaired a meeting with top officials as fresh spurt in cases in countries like Japan, South Korea, Brazil, China, and the US.
Fri, Dec 09, 2022
Stocks to buy: One may consider the brokerage recommendations for positive yield.
Thu, Nov 24, 2022
Nifty, Sensex, Top Gainers, Top Losers, Apollo Hospital, Infosys, Cipla: According to the market analyst, the rally in the final hour can be attributed to a quick covering move as call writers were trapped.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.